Financial news, mergers and acquisitions, partnerships, and alliances.
According to the complaint, the allegedly infringing products include all those that use nucleotides with a 3’-O-azidomethyl blocking group.
The company said testing revenues rose 54 percent during the quarter, and that it provided 63 percent more patient results year over year.
ZPredicta's platform is designed to integrate organ-specific cellular and extracellular elements into 3D culture models for in vitro cancer drug testing.
The financing follows InformedDNA's signing of definitive agreements to receive growth capital investments with a number of investment groups.
Test volumes, revenues per test and costs per test improved during the quarter, the company said.
A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.
A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.
NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.
In Nature this week: epigenetic factors that prevent healthy aging and more.